MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway

Zhengping Huang, Shan Xing, Meng Liu, Weiming Deng, Yunqing Wang, Zhixiang Huang, Yukai Huang, Xuechan Huang, Chi-Wei Wu, Xin Guo, Xia Pan, Jiawei Jiang, Fan Feng, Li TBioscience 2019 · DOI

TL;DR

This study identifies miR-26a-5p as a key microRNA that is upregulated in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS). By targeting PTEN, miR-26a-5p promotes FLS proliferation, invasion, and resistance to apoptosis, likely through activating the PI3K/AKT pathway, suggesting miR-26a-5p as a potential therapeutic target for RA.

What Problem Does This Paper Address?

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and destruction, with fibroblast-like synoviocytes (FLS) playing a central role in its pathogenesis. RA-FLS exhibit aggressive features like hyperproliferation, invasion, and resistance to apoptosis. While microRNAs (miRNAs) are known to be involved in various pathological conditions, the specific molecular mechanisms driving RA-FLS behavior and the role of individual miRNAs in this process remain incompletely understood. This paper aims to identify dysregulated miRNAs in RA-FLS and elucidate the functional role of a specific miRNA, miR-26a-5p, in RA pathogenesis.

Methods

The researchers employed a multi-pronged approach to investigate miR-26a-5p's role in RA-FLS:

  • Microarray Analysis: Used to screen for differentially expressed miRNAs in RA-FLS compared to control FLS from trauma patients.
  • Quantitative Real-Time PCR (qRT-PCR): Used to validate the expression levels of specific miRNAs identified by microarray, particularly miR-26a-5p, in RA-FLS, osteoarthritis (OA)-FLS, and trauma-FLS.
  • Functional Assays:
    • Cell Proliferation Assay (CCK-8): To assess the impact of miR-26a-5p modulation on FLS growth.
  • Cell Cycle Assay (Flow Cytometry): To determine how miR-26a-5p affects the progression of FLS through different cell cycle phases.
  • Apoptosis Assay (Annexin V-FITC/PI staining and Flow Cytometry): To measure the effect of miR-26a-5p on programmed cell death in FLS.
  • Cell Invasion Assay (Transwell Matrigel Invasion Assay): To evaluate the ability of FLS to invade surrounding tissues.
  • Bioinformatics Analysis & Molecular Validation:
    • Target Prediction: Bioinformatics tools (TargetScan, microRNA.org, PicTar) were used to predict potential mRNA targets of miR-26a-5p.
  • Dual Luciferase Reporter Assay: To confirm direct binding of miR-26a-5p to the 3'UTR of its predicted target, PTEN.
  • Western Blot: To assess the protein expression levels of PTEN and key components of the PI3K/AKT pathway (AKT and phosphorylated AKT) following miR-26a-5p modulation.
  • Pharmacological Inhibition: Used the PI3K/Akt inhibitor LY294002 to further investigate the role of the PI3K/AKT pathway.

Datasets

The study utilized synovial tissue specimens collected from patients undergoing knee joint replacement surgery or synovial biopsy. These included:

  • Eight patients with Rheumatoid Arthritis (RA).
  • Nine patients with Osteoarthritis (OA).
  • Eight patients with joint trauma (serving as controls).

For microarray analysis, RNA samples from three RA patients and three knee joint trauma patients were used. For qRT-PCR, samples from eight RA patients, eight OA patients, and nine knee joint trauma patients were analyzed.

Key Insights and Ideas

  • miR-26a-5p is a key player in RA-FLS: The study firmly establishes miR-26a-5p as a significantly upregulated miRNA in RA-FLS, distinguishing it from FLS in non-inflammatory conditions.
  • miR-26a-5p drives aggressive FLS behavior: The findings reveal that increased miR-26a-5p directly promotes FLS proliferation, enhances their ability to invade tissues, and makes them more resistant to apoptosis – all hallmarks of RA pathogenesis.
  • PTEN is a direct target: The research provides strong evidence that miR-26a-5p directly targets the tumor suppressor gene PTEN, a crucial regulator of cell growth and survival.
  • The PI3K/AKT pathway is activated: The study demonstrates that miR-26a-5p's pro-tumorigenic effects on FLS are mediated by the activation of the PI3K/AKT signaling pathway, which is a well-known pathway involved in cell proliferation, survival, and invasion.
  • A potential therapeutic avenue: The identification of miR-26a-5p as a driver of RA-FLS pathology and its link to the PTEN/PI3K/AKT pathway opens up possibilities for developing novel therapeutic strategies targeting this miRNA.

Key Results

  • Upregulation of miR-26a-5p: miR-26a-5p expression was found to be 5.1-fold higher in cultured RA-FLS compared to OA-FLS and 6.1-fold higher compared to trauma-FLS (P<0.01).
  • Promotion of Proliferation: Overexpression of miR-26a-5p significantly increased RA-FLS proliferation, with cell proliferation rates being higher on day 4 in mimic-transfected cells compared to controls (520.06% vs 419.88%, P<0.01). Conversely, inhibiting miR-26a-5p reduced proliferation.
  • Enhanced G1/S Transition: miR-26a-5p mimic treatment led to a decrease in G1 phase cells and an increase in S phase cells, indicating accelerated cell cycle progression.
  • Inhibition of Apoptosis: Overexpression of miR-26a-5p significantly reduced late apoptosis rates in RA-FLS.
  • Increased Invasion: RA-FLS treated with miR-26a-5p mimic showed a significant increase in invasion through Matrigel compared to controls (94 vs 51.5 cells, P<0.01).
  • PTEN Regulation: miR-26a-5p mimic significantly decreased PTEN protein expression, while miR-26a-5p inhibitor increased it (P<0.01).
  • PI3K/AKT Pathway Activation: Overexpression of miR-26a-5p led to increased phosphorylation of AKT (p-AKT), indicating activation of the PI3K/AKT pathway. The p-AKT/AKT ratio was significantly higher in miR-26a-5p mimic-treated cells (P<0.05).

Limitations and Future Work

The authors acknowledge that their study suggests miR-26a-5p's role in RA-FLS is "at least partially" attributed to its activation of the PI3K/AKT pathway, implying other mechanisms might also be involved. The study focuses on in vitro experiments, and future work should aim to validate these findings in animal models of RA and explore the clinical relevance of targeting miR-26a-5p in human RA patients. Further research could also investigate other potential targets of miR-26a-5p and their contribution to RA pathogenesis. The paper concludes by stating that miR-26a-5p is "likely to be a clinically helpful target for novel therapeutic strategies in RA," underscoring the translational potential of their findings.

Summary updated

Abstract

Behavior alterations in fibroblast-like synoviocytes (FLS) contribute to a pivotal role in pathogenesis of rheumatoid arthritis (RA). MiRNAs are closely involved in a variety of pathologic conditions. In the present study, we aimed to screen for the aberrant expression of miRNAs in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) to further identify the altered expression of miR-26a-5p in RA-FLS and to investigate the role of miR-26a-5p in RA. The altered expression of miR-26a-5p in RA-FLS was screened by microarray analysis and confirmed by quantitative real time PCR. The effect of miR-26a-5p on proliferation, cell cycle, apoptosis, and invasion in RA-FLS were studied. The verification of miR-26a-5p target mRNA and downstream signaling pathway was elucidated by bioinformatics analysis, dual luciferase reporter assay, and western blot. Expression of miR-26a-5p was higher in RA-FLS than in fibroblast-like synoviocytes from osteoarthritis patients and trauma patients. Overexpression of miR-26a-5p RA-FLS promoted cells proliferation, G1/S transition, cells invasion, and resisted apoptosis in RA-FLS, whereas it led to contrary effects when inhibiting the expression of miR-26a-5p. The 3'UTR of tensin homolog (PTEN) was directly targetted by miR-26a-5p and activation of phosphoinositide 3-kinase (PI3K)/AKT pathway was observed when overexpression of miR-26a-5p. Our study suggested that miR-26a-5p has a complementary role in cells proliferation, invasion, and apoptosis of RA-FLS, which may be attributed to its activation effect on PI3K/AKT signaling pathway via targetting PTEN. MiR-26a-5p is likely to be a clinically helpful target for novel therapeutic strategies in RA.
BibTeX
@inproceedings{huang2019mir,
  author = {Zhengping Huang and Shan Xing and Meng Liu and Weiming Deng and Yunqing Wang and Zhixiang Huang and Yukai Huang and Xuechan Huang and Chi-Wei Wu and Xin Guo and Xia Pan and Jiawei Jiang and Fan Feng and Li T},
  title = {{MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway}},
  booktitle = {Bioscience},
  year = {2019},
  doi = {10.1042/bsr20182192},
}
Figure